SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as strong semiconductor earnings and anticipation for upcoming mega-cap tech results propel the Nasdaq 100 to new all-time highs. Bulls are celebrating the relentless ascent, frequently dismissing persistent warnings of market manipulation and overbought conditions from bears. The community widely notes the market's tendency to consistently 'buy any dip,' challenging traditional short-selling strategies amid this powerful upward momentum.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is currently trending as its highly engaged community fervently champions the 'OG meme' narrative, positioning Rage Comics as a foundational 'meme reset' for the crypto market. Enthusiasts demonstrate strong conviction, actively developing an ecosystem with platforms like RageMaker and RageGames, while rallying others to 'Return to the Memes' and 'Rage On' to establish dominance in the sector. The community believes in the power of real cults behind original memes to move the entire market, advocating for consistency and building over fleeting trends.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as it surges to new all-time highs, ahead of the anticipated FOMC decision and a wave of major tech earnings reports. Bulls are celebrating the strong market momentum, while bears express caution, warning of a potential "blow off top" and market manipulation. The community is actively debating the sustainability of this rally amid a weakening dollar and surging precious metals.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors actively discuss a substantial direct offering to a new institutional investor, widely seen as a strategic move to de-risk its Phase 3 MASH trial and enhance leverage for potential partnerships or acquisition. This financing, combined with recent strong analyst price targets and FDA Breakthrough Therapy Designation for pemvidutide, has ignited debate within the community. While many anticipate significant upside and a short squeeze, others voice caution regarding the dilution and its immediate market impact.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is currently trending as a critical beneficiary of the ongoing AI boom, fueled by record orders, strong guidance, and increased capital expenditures from major chipmakers like TSMC. The community is actively discussing its significant parabolic move, with debates around its valuation and potential for a stock split, while many highlight its indispensable technological monopoly in advanced semiconductor manufacturing.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending strongly following reports that China has approved the import of its H200 AI chips, a move seen by many as solidifying the company's leadership in the global AI hardware market. This development, alongside ongoing community discussions about its attractive valuation and the massive capital expenditure in AI infrastructure, is fueling widespread bullish sentiment and expectations for continued growth.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is actively discussed following an accidental email that prematurely revealed impending widespread layoffs, a move prompting debate among investors. Many view these organizational changes and a strategic shift in grocery focus as a push for greater AI-driven efficiency and cost optimization, while others question the impact on employees and overall business priorities. This ongoing streamlining is set against the backdrop of Amazon Web Services (AWS) continuing to secure major cloud contracts.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a significant rally to new all-time highs, driven by growing community concerns over a weakening US dollar and increasing national debt, alongside broader geopolitical uncertainties. Investors are actively discussing a rotation into precious metals as a secure hedge, with many predicting substantial further gains while a minority cautiously eye a potential correction after the rapid ascent.

Logitech International SA is a holding company, which engages in the design of software-enabled hardware solutions. Its portfolio includes gaming, keyboards and combos, pointing devices, video collaboration, webcams, tablet accessories, and headsets. Its cloud based services includes video conferencing platforms, esports or video games, music streaming platforms, content streaming platforms, and and creativity and productivity platforms. It enhances through software, including machine learning and artificial intelligence. The company was founded by Daniel Borel, Pierluigi Zappacosta, and Giacamo Marini on October 2, 1981 and is headquartered in Lausanne, Switzerland.

Logitech International S.A.

Logitech (LOGI) is trending after delivering a robust earnings report that surpassed expectations and led to a raised fiscal year outlook, driven by strong demand across peripherals, gaming, and productivity tools. Community discussion is actively debating whether this signals a sustainable growth trajectory, with many focusing on the company's strategic shift towards business solutions, AI integration, and diversified supply chains, while also considering prevailing macroeconomic uncertainties and mixed analyst sentiment.

Stride, Inc. is a technology-based educational company, which engages in the provision of proprietary and third-party curriculum, software systems and educational services. It also offers online curriculum and career services to middle and high school students, under the Destinations Career Academy brand name. The company was founded by Ronald J. Packard in 2000 and is headquartered in Reston, VA.

Stride Inc

Stride Inc. (LRN) is trending sharply following a significant earnings beat and robust enrollment growth, particularly in its career learning segment. The company's newly authorized $500 million stock repurchase program is fueling strong community discussion about its undervaluation and potential for a substantial short squeeze, especially given its recovery from prior market pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD

Perkins Capital Management Inc. purchased a new stake in shares of Lucid Diagnostics Inc. (NASDAQ:LUCD - Free Report) in the 3rd quarter, according to its most recent filing with the Securities...

What's Going On With PAVmed Shares Thursday?

PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contractread more...

Why Is PAVmed Stock Skyrocketing Wednesday?

PAVmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.read more...

<ul class="summary-bullets"><li>The contract is issued under the VA Federal Supply Schedule and includes pre-negotiated pricing.</li><li>The agreement provides more than nine million enrolled veterans access to&nbsp;esophageal&nbsp;precancer testing.</li><li>Trading in PAVM shares was halted at 09:58 ET.</li></ul>Shares of PAVmed Inc. (PAVM) jumped more than 250% on Wednesday morning after its subsidiary, Lucid Diagnostics Inc. (LUCD), won a contract from the U.S. Department of Veterans Affairs (VA) to supply its EsoGuard Esophageal DNA Test for detecting esophageal precancer across the VA healthcare system.The agreement provides more than nine million enrolled veterans access to&nbsp;esophageal&nbsp;precancer testing.<a href="https://stocktwits.com/symbol/PAVM">PAVM</a> was among the top trending tickers on Stocktwits at the time of writing. <a href="https://stocktwits.com/symbol/LUCD">LUCD</a> shares jumped 23% to their highest levels since May 2025.<h2 class="st-heading-2">Contract Details</h2>The contract is issued under the VA Federal Supply Schedule and includes pre-negotiated pricing that aligns with the Medicare reimbursement rate set by the Centers for Medicare &amp; Medicaid Services. This structure allows VA hospitals and clinics nationwide to procure EsoGuard through a single, standardized framework.“The VA operates at significant clinical and operational scale, and selection by a healthcare system of this size reflects the strength of the clinical evidence supporting EsoGuard,” said Shaun O'Neil, President and Chief Operating Officer of Lucid Diagnostics.&nbsp;&nbsp;Lucid Diagnostics focuses on early cancer prevention diagnostics, particularly for patients with gastroesophageal reflux disease who face an elevated risk of developing esophageal precancer and cancer.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for PAVM on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, accompanied by ‘extremely high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/PAVMED_jpg_a10dfa8673.webp" alt="PAVMED.jpg" width="925" height="96"><figcaption>PAVM's Sentiment Meter and Message Volumes at 10:20 a.m. ET on Jan. 21, 2026 | Source: Stocktwits</figcaption></figure>Sentiment for LUCD changed to ‘bullish’ from ‘neutral’ a day earlier, while message volumes were ‘extremely high’.One user believes the news has ‘real value’.<stembedurl>https://stocktwits.com/pow7904/message/642397455</stembedurl>PAVmed implemented a 1-for-30 reverse stock split on January 2.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/gold-rises-to-record-highs-as-investors-seek-out-safe-haven-assets/cmUDMEjR4fK">Gold Jumps To All-Time Highs – Veteran trader Peter Brandt Says $8,000 An Ounce Is On The Cards</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs?

PAVM Stock - The company’s subsidiary, Lucid Diagnostics, secured a contract from the U.S. Department of Veterans Affairs to provide its EsoGuard Esophageal DNA Test for the detection of esophageal precancer.

Equity

The company’s subsidiary, Lucid Diagnostics, secured a contract from the U.S. Department of Veterans Affairs to provide its EsoGuard Esophageal DNA Test for the detection of esophageal precancer.

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard PR Newswire NEW YORK, Jan. 21...

Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9% - Here's Why

Lucid Diagnostics (NASDAQ:LUCD) Trading 0.9% Higher - Should You Buy...

PAVmed Announces Reverse Stock Split

PAVmed Announces Reverse Stock Split PAVmed Announces Reverse Stock Split PR Newswire NEW YORK, Dec. 30, 2025 NEW YORK, Dec. 30, 2025 /PRNewswire/ --PAVmed Inc.(NASDAQ: PAVM) ('PAVmed' or the...

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Lucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) has been given an average rating of "Moderate Buy" by the five brokerages that are covering the company, MarketBeat reports. One equities...

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection Lucid Diagnostics Announces Positive Data from the Largest Reported...

Wednesday Sector Laggards: Diagnostics, Medical Instruments & Supplies

In trading on Wednesday, diagnostics shares were relative laggards, down on the day by about 0.4%. Helping drag down the group were shares of Nutex Health, off about 5.7% and shares of Lucid...

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Current Price	$1.22
Prev Close	$1.23
Open	$1.23
Dividend Yield	0.00%
50-Day Moving Average	$1.11
Beta	0.59
Avg. Volume	692,970.45
PE Ratio	-1.36

52-Week High	$1.80
52-Week Low	$0.8804
Market Capitalization	$161.25M
EPS (Annual)	-$1.05
Price to Book	-5.62
Revenue Per Employee	$60,361.11
Enterprise Value/EBITDA	N/A

LUCD
Lucid Diagnostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LUCD News

LUCDLucid Diagnostics Inc